Physician profile
Lindsey A Feilner
NPI 1730720434
$686.80
in general payments reported to CMS, 2019-2025
16 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $618 · 2022: $68.32.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $174.29 | 2021-2022 | |
| Grifols USA, LLC | $127.41 | 2021-2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $48.99 | 2021 | |
| Electromed, INC. | $48.48 | 2021 | |
| Pharming Healthcare, INC. | $46.74 | 2021 | |
| Horizon Therapeutics Plc | $42.33 | 2021 | |
| Sanofi-Aventis U.S. LLC | $33.52 | 2021 | |
| Genzyme Corporation | $32.54 | 2021 | |
| Glaxosmithkline, LLC. | $23.05 | 2021 | |
| Alk-Abello, INC | $19.47 | 2021 | |
| United Therapeutics Corporation | $19.39 | 2022 | |
| Teva Pharmaceuticals USA, INC. | $19.00 | 2021 | |
| Regeneron Healthcare Solutions, INC. | $13.83 | 2021 | |
| Philips North America LLC | $13.26 | 2021 | |
| Genentech USA, INC. | $12.85 | 2021 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kaleo, INC. | $11.65 | 2021 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lindsey Feilner listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.